Definition/General

Introduction:
-Umbilical cord stricture represents a focal narrowing of the umbilical cord diameter
-It occurs due to localized compression or developmental abnormality
-The stricture involves all cord components including vessels and Wharton jelly
-It can lead to fetal compromise and adverse outcomes.
Origin:
-Originates from developmental anomalies during cord formation
-Results from localized pressure effects during gestation
-May be associated with cord entanglement or compression
-Can develop from inflammatory processes affecting cord structure
-Associated with vascular compromise and reduced blood flow.
Classification:
-Classified as congenital or acquired strictures
-Mild stricture (minimal diameter reduction)
-Moderate stricture (significant narrowing)
-Severe stricture (marked constriction with vascular compromise)
-Multiple strictures may occur along cord length.
Epidemiology:
-Rare condition occurring in 0.1-0.5% of pregnancies
-More common with advanced maternal age
-Associated with oligohydramnios
-Higher incidence in multiple gestations
-Male fetuses show slightly higher predisposition
-Risk increases with cord entanglement and abnormal presentations.

Clinical Features

Presentation:
-Fetal growth restriction (most common presentation)
-Abnormal fetal heart rate patterns
-Oligohydramnios in severe cases
-Reduced fetal movements reported by mother
-Abnormal Doppler studies showing increased resistance
-May present as intrauterine fetal demise in severe cases.
Symptoms:
-Maternal perception of decreased fetal movement
-Abnormal non-stress test results
-Variable decelerations during monitoring
-Growth discordance in multiple gestations
-Maternal anxiety due to reduced fetal activity
-Preterm labor may occur in severe cases.
Risk Factors:
-Advanced maternal age (>35 years)
-Oligohydramnios throughout pregnancy
-Multiple gestation pregnancies
-Cord entanglement or true knots
-Maternal diabetes mellitus
-Intrauterine infections
-Previous history of cord abnormalities
-Genetic syndromes affecting connective tissue.
Screening:
-Routine ultrasonography during second and third trimesters
-Doppler studies of umbilical vessels
-Biophysical profile assessment
-Non-stress testing in third trimester
-Amniotic fluid volume assessment
-Fetal growth monitoring with serial measurements.

Master Cord Stricture Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Focal narrowing of umbilical cord with visible constriction
-Pale or discolored area at stricture site
-Normal cord diameter proximal and distal to stricture
-Reduced cord circumference at affected area
-May show surface irregularities or grooves.
Characteristics:
-Firm consistency at stricture site compared to normal cord
-Smooth or irregular surface depending on cause
-Color may range from pale to gray-white
-Visible vessel compression within stricture
-Surrounding cord may appear normal or swollen.
Size Location:
-Stricture length varies from 0.5-5 cm
-Can occur anywhere along cord length
-Mid-cord location most common
-May be multiple strictures in severe cases
-Diameter reduction ranges from 20-80% of normal cord diameter.
Multifocality:
-Single stricture in majority of cases (80-90%)
-Multiple strictures in 10-20% of cases
-May be associated with other cord abnormalities
-Segmental involvement possible in severe cases
-Can occur with cord knots or entanglement.

Microscopic Description

Histological Features:
-Compressed Wharton jelly with reduced mucopolysaccharide content
-Vascular compression affecting all three vessels
-Reduced vessel lumen diameter
-Smooth muscle hypertrophy in vessel walls
-Fibrosis may be present in chronic cases.
Cellular Characteristics:
-Compressed fibroblasts within Wharton jelly matrix
-Endothelial flattening in compressed vessels
-Smooth muscle cell changes in arterial walls
-Inflammatory infiltrate may be present
-Collagen deposition in chronic strictures.
Architectural Patterns:
-Concentric compression pattern affecting all cord components
-Asymmetric involvement possible with external pressure
-Vessel wall thickening with luminal narrowing
-Wharton jelly condensation around vessels
-Fibrotic bands may be present in severe cases.
Grading Criteria:
-Mild stricture (10-30% diameter reduction, minimal vascular compromise)
-Moderate stricture (30-60% reduction, moderate vascular changes)
-Severe stricture (>60% reduction, significant vascular compromise)
-Assessment includes vessel patency and tissue viability.

Immunohistochemistry

Positive Markers:
-Smooth muscle actin highlights vessel walls
-CD31 demonstrates endothelial integrity
-Collagen IV shows basement membrane preservation
-Vimentin stains fibroblasts in Wharton jelly
-Desmin positive in smooth muscle cells.
Negative Markers:
-Cytokeratin typically negative in normal cord tissue
-S-100 negative (helps exclude neural tissue)
-CD68 negative unless inflammatory infiltrate present
-Trichrome stain may show increased collagen in chronic cases.
Diagnostic Utility:
-IHC helps assess vessel integrity and patency
-Confirms endothelial viability in compressed vessels
-Demonstrates smooth muscle preservation or loss
-Helps identify inflammatory components
-Useful for assessing tissue viability at stricture site.
Molecular Subtypes:
-Assessment focuses on vascular integrity markers
-Hypoxia markers (HIF-1α) may be positive
-Apoptosis markers (TUNEL, caspase-3) in severe cases
-Proliferation markers (Ki-67) typically low
-Angiogenesis markers (VEGF) may be elevated.

Molecular/Genetic

Genetic Mutations:
-Usually non-genetic developmental anomaly
-Associated with connective tissue disorders in rare cases
-Collagen gene mutations may predispose to stricture formation
-Vascular development genes may be involved
-Extracellular matrix genes affect Wharton jelly composition.
Molecular Markers:
-Hypoxia-inducible factors may be elevated
-Matrix metalloproteinases involved in tissue remodeling
-Growth factors (PDGF, TGF-β) affect vessel development
-Collagen synthesis markers may be altered
-Apoptosis pathways activated in severe compression.
Prognostic Significance:
-Severity of stricture correlates with fetal outcomes
-Vascular compromise predicts growth restriction
-Location and multiplicity affect prognosis
-Associated anomalies worsen outcomes
-Gestational age at diagnosis influences management.
Therapeutic Targets:
-Management focuses on fetal monitoring and timely delivery
-Doppler surveillance of fetal vessels
-Growth assessment and biophysical profile monitoring
-Steroid administration for fetal lung maturity
-Delivery planning based on severity and gestational age.

Differential Diagnosis

Similar Entities:
-Umbilical cord knots (true or false knots with different morphology)
-Cord hematoma (localized bleeding with different gross appearance)
-Cord tumors (hemangioma, teratoma with distinct histology)
-Cord torsion (spiral pattern, different mechanism)
-Velamentous insertion (different location and pattern).
Distinguishing Features:
-Cord stricture: focal narrowing with smooth transition
-Cord stricture: concentric compression pattern
-Cord knots: looped configuration with crossing vessels
-Cord hematoma: hemorrhage and blood products
-Cord tumors: mass lesion with specific tissue types
-Torsion: spiral configuration with rotational changes.
Diagnostic Challenges:
-Distinguishing from normal cord variations in diameter
-Differentiating from artificial compression during processing
-Identifying multiple strictures along cord length
-Assessing functional significance of mild strictures
-Correlating morphology with clinical findings.
Rare Variants:
-Segmental stricture involving long cord segments
-Multiple strictures with intervening normal cord
-Progressive stricture developing during pregnancy
-Inflammatory stricture secondary to infection
-Post-procedure stricture following interventions.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

Umbilical cord measuring [length] cm with focal stricture at [location]

Diagnosis

Umbilical cord stricture

Severity Classification

Severity: [mild/moderate/severe] with [percentage]% diameter reduction

Histological Features

Shows [degree] compression of Wharton jelly with [vascular changes]

Location and Extent

Located at [distance] cm from [fetal/placental] insertion, extending [length] cm

Vascular Assessment

Umbilical vessels show [degree] of compression with [patency status]

Associated Findings

Associated findings: [list any additional abnormalities]

Clinical Correlation

Clinical history of [symptoms/findings] correlates with [severity] of stricture

Prognostic Factors

Risk factors for fetal compromise: [list relevant factors]

Final Diagnosis

Umbilical cord stricture, [severity grade], with [clinical significance]